|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Real estate investments | ||||||||||||||||||||
| Real estate property | ||||||||||||||||||||
| Accumulated depreciation | ||||||||||||||||||||
| Real estate property, net | ||||||||||||||||||||
| Real estate developments | ||||||||||||||||||||
| Investments in sales-type leases, net of allowances (credit losses) of $45 as of December 31, 2025 | ||||||||||||||||||||
| Investments in real estate joint ventures and partnerships | ||||||||||||||||||||
| Real estate intangible assets, net | ||||||||||||||||||||
| Real estate investments, net | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Accounts receivable and retention, net of allowances (credit losses and doubtful accounts) of $1.3 million and $3.3 million as of December 31, 2021 and 2020, respectively | ||||||||||||||||||||
| Accounts receivable, net of allowances (credit losses and doubtful accounts) of $1,219 and $1,701 as of December 31, 2025 and 2024, respectively | ||||||||||||||||||||
| Other property, net | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other receivables, net of allowance (credit losses) of $2,336 and $2,393 as of December 31, 2025 and 2024, respectively | ||||||||||||||||||||
| Straight-line rent receivable | ||||||||||||||||||||
| Investments in other joint ventures and partnerships | ||||||||||||||||||||
| Prepaid expenses and other assets | ||||||||||||||||||||
| Assets held for sale | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND EQUITY | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Notes payable and other debt | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Accrued post-retirement benefits | ||||||||||||||||||||
| Refund liability | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Accrued dividends | ||||||||||||||||||||
| Real estate intangible liabilities, net | ||||||||||||||||||||
| Accrued and other liabilities | ||||||||||||||||||||
| Liabilities associated with assets held for sale | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Redeemable Noncontrolling Interest (Note 2) | ||||||||||||||||||||
| Equity: | ||||||||||||||||||||
| Common stock - no par value; authorized, 225,000,000 shares; outstanding 72,820,075 and 72,633,866 shares at December 31, 2025 and 2024, respectively | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Distributions in excess of accumulated earnings | ||||||||||||||||||||
| Total shareholders' equity | ||||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||||
Loading...
